TENALISIB
Rhizen receives USFDA fast track designation for cancer drugUSFDA has granted Fast Track Designation for RP6530.. for the treatment of patients with relapsed/refractory peripheral T- cell lymphoma (P...11 Dec, 2017, 12.22 PM IST
Load More